...
首页> 外文期刊>Biomarker Research >A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature
【24h】

A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature

机译:成年B-ALL超双倍体核型背景下涉及TCF3-PBX1融合的(1; 19)易位:病例报告和文献综述

获取原文

摘要

BackgroundThe t(1;19)(q23;p13), which can result in the TCF3-PBX1 chimeric gene, is one of the most frequent translocations in B-acute lymphoblastic leukemia (B-ALL) and is observed in both adult and pediatric populations at an overall frequency of 6%. It can occur in a balanced or unbalanced form and as a sole abnormality is associated with an intermediate prognosis. Additionally, this translocation is observed in the context of hyperdiploid B-ALL, in which case it is associated with a poor prognosis. However, due to different translocation partner genes at chromosomes 1 and 19, distinct subtypes of hyperdiploid B-ALL with t(1;19)/der(19)t(1;19) are recognized based on the presence or absence of the TCF3-PBX1 fusion gene, but the cytogenetic and etiologic differences between the two remain understudied. FindingsWe report a case of an adult with a history of relapsed precursor B-ALL whose conventional cytogenetics showed an abnormal female karyotype with both hyperdiploidy and a t(1;19)(q23;p13). Fluorescence in situ hybridization (FISH) on previously G-banded metaphases using the LSI TCF3/PBX1 Dual Color, Dual Fusion Translocation Probe confirmed the presence of the TCF3-PBX1 gene fusion. ConclusionsThis particular pattern with a TCF3-PBX1 fusion within the context of a hyperdiploid karyotype is seen in B-ALL and is usually associated with a poor outcome. This case is one of only a few cases with both hyperdiploidy and a confirmed TCF3 - PBX1 fusion, demonstrating the importance of using FISH for proper molecular classification of these cases in order to distinguish them from those with hyperdiploidy but no TCF3-PBX1 fusion gene. Such molecular studies may provide insight into the precise differences between TCF3-PBX1 positive and negative hyperdiploid B-ALL bearing the t(1;19)(q23;p13).
机译:背景可能导致TCF3-PBX1嵌合基因的t(1; 19)(q23; p13)是B急性淋巴母细胞白血病(B-ALL)中最常见的易位之一,在成人和儿科患者中都观察到人口的整体频率为6%。它可以平衡或不平衡的形式发生,并且由于唯一的异常与中间预后相关。另外,在超二倍体B-ALL的情况下观察到这种易位,在这种情况下它与不良的预后有关。但是,由于在1号和19号染色体上有不同的易位伴侣基因,因此根据是否存在TCF3来识别具有t(1; 19)/ der(19)t(1; 19)的超二倍体B-ALL的不同亚型。 -PBX1融合基因,但两者之间的细胞遗传学和病因学差异仍在研究中。研究结果我们报告了一例有复发前体B-ALL病史的成年人,其常规细胞遗传学显示异常的女性核型,具有双倍体和t(1; 19)(q23; p13)。使用LSI TCF3 / PBX1双色双融合易位探针在先前G带中期的荧光原位杂交(FISH)证实了TCF3-PBX1基因融合的存在。结论在B-ALL中可以看到这种在超二倍体核型背景下与TCF3-PBX1融合的特殊模式,通常与不良预后相关。该病例是仅有的具有双倍体性和TCF3-PBX1融合体的少数病例之一,这表明使用FISH对这些病例进行正确的分子分类以将其与具有高二倍体性但没有TCF3-PBX1融合基因的病例区分开来的重要性。此类分子研究可能会提供带有t(1; 19)(q23; p13)的TCF3-PBX1正负双倍体B-ALL之间精确的区别。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号